Jason O'connor

This inventor holds 30 USPTO granted patents and 20 published patent applications and 11 EPO patents, primarily in Automated Medication Delivery. Top assignee: Insulet Corporation. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason O'connor. Retrieved from https://idiyas.com/inventor/jason-o-connor-pfa1dnwm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 20)

% Patents Active = 90.0

EPO Patents = 11 (Patent Applications = 65)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 18(Granted Patents)

Company Filing History:

29 out of 248

Insulet Corporation

patents

where one patent can have more than one assignee

Years Active: 2023-2026

Loading Chart...

Areas of Expertise:

Medication Delivery

Insulin Systems

Drug Delivery Devices

User Adaptability

Automatic Drug Delivery

Graphical User Interface

Wearable Systems

Hypoglycemia Risk

Personalized Dosages

Adaptive Control

Fuzzy Logic

Closed Loop Systems

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12763189 - Automated artificial pancreas insulin onboarding and total daily insulin delivery adaptivity based on insulin history (2026-10-13),

2. 12763187 - Systems and methods for ensuring sufficient bolus dosing for meal compensation (2026-10-13),

3. 12758707 - Fluid delivery device, transcutaneous access tool and fluid drive mechanism for use therewith (2026-10-13),

4. 12752053 - Medication delivery system with graphical user interface (2026-10-06),

5. 12741094 - Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns (2026-09-22),

6. 12741090 - Automatic drug delivery system having multiple communication options (2026-09-22),

7. 12741086 - Techniques to increase rate of adaptivity for total daily insulin (2026-09-22),

8. 12728203 - Techniques for recommending rescue carbohydrate ingestion in automatic medication delivery systems (2026-09-08),

9. 12714785 - Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns (2026-08-25),

10. 12708709 - ADAPTATION OF AUTOMATIC INSULIN DELIVERY (AID) FOR USERS WITH BASAL TO BOLUS MISMATCH (2026-08-18),

11. 12697472 - Drug delivery device including pump with floating microneedle assembly (2026-08-04),

12. 12691222 - Techniques for determining medication correction factors in automatic medication delivery systems (2026-07-28),

13. 12636431 - Drug delivery insertion apparatuses and system (2026-05-26),

14. 12576206 - Wearable automated medication delivery system (2026-03-17),

15. 12569619 - Techniques for determining automated insulin delivery dosages (2026-03-10),

Title: Innovations by Jason O'Connor

Introduction

Jason O'Connor is a notable inventor based in Acton, MA, who has made significant contributions to the field of medical technology. With a total of 11 patents to his name, O'Connor has focused on developing advanced solutions for diabetes management. His work primarily revolves around wearable drug delivery devices that enhance the quality of life for individuals with diabetes.

Latest Patents

One of O'Connor's latest patents is titled "Activity mode for artificial pancreas system." This invention describes a wearable drug delivery device that implements a diabetes treatment plan tailored for the user. The device includes a controller that directs its operation and offers a selectable activity mode. This mode is designed to reduce the likelihood of hypoglycemia during periods of increased insulin sensitivity and hyperglycemia during times of increased insulin requirements. The activity mode can be activated manually by the user or automatically based on detected activity levels or locations.

Another significant patent is for a "medicament delivery device with an adjustable and piecewise analyte level cost component." This invention modifies the glucose cost component of an insulin delivery device's control loop to address persistent positive low-level glucose excursions. It allows for the use of different glucose cost component functions for varying glucose levels, employing a piecewise approach to optimize insulin delivery.

Career Highlights

O'Connor is currently employed at Insulet Corporation, a company known for its innovative diabetes management solutions. His work at Insulet has positioned him as a key player in the development of cutting-edge medical devices that improve patient outcomes.

Collaborations

Throughout his career, O'Connor has collaborated with talented individuals such as Joon Bok Lee and Yibin Zheng. These partnerships have contributed to the advancement of his inventions and the overall mission of improving diabetes care.

Conclusion

Jason O'Connor's contributions to medical technology, particularly in diabetes management, highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to developing solutions that address real-world challenges faced by individuals with diabetes.

Profile summary based on public USPTO records.